Unknown PHASE4 INTERVENTIONAL 2-arm NCT02580227

Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures

The Effect of Preoperative Tranexamic Acid on Blood Loss and Transfusion Rates in Intertrochanteric and Subtrochanteric Femur Fractures.

Sponsor: Good Samaritan Regional Medical Center, Oregon

Conditions Hip Fractures Surgical Blood Loss

Interventions Placebo Tranexamic Acid

Updated 6 times since 2017 Last updated: Oct 27, 2015 Started: Jun 30, 2015 Primary completion: Aug 31, 2016 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02580227, this PHASE4 trial focuses on Hip Fractures and Surgical Blood Loss and remains ongoing. Sponsored by Good Samaritan Regional Medical Center, Oregon, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Oct 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Oct 2017 [monthly]

Recruiting PHASE4

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Good Samaritan Regional Medical Center, Oregon

Data source: Good Samaritan Regional Medical Center, Oregon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Corvallis, United States